Bringing the fundamentals into focus…
Back to IDEXX Laboratories, Inc.
How IDEXX Laboratories, Inc. stacks up
IDXX · against 57 other Healthcare companies of similar size
Growth
58/ 100
Above the middle of the pack.
Ranked #24 of 58 · scores higher than 56% of peers
Bars: peers in each 10-point band of the growth score12 peers with a growth score of 50–59, including IDXX · Click a bar to see the companies
Why growth scores 58?
Weighted metrics compared with all Healthcare companies.Its metrics sit close to the Healthcare norm.
- Earnings per share growth is close to the peer norm. Earnings per share growth: 17.4% vs peer median 9.8%
- 3-year revenue growth is close to the peer norm. 3-year revenue growth: 9.0% vs peer median 5.8%
- faster revenue growth over the last year: stronger than 67% of peers. Revenue growth: 12.8% vs peer median 6.1%
Metric by metric
Position: dot = IDXX, ranked from the worst peer (left) to the best (right); tick = middle, shaded = middle half of peers.| Metric | IDXX | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Revenue growthHigher is better · 58 reported | 12.8% | 9.6% | 67% | 33% | |
| Earnings per share growthHigher is better · 47 reported | 17.4% | 12.7% | 61% | 33% | |
| 3-year revenue growthHigher is better · 58 reported | 9.0% | 6.6% | 60% | 33% |
Ranking by growth score
Top 5 and the companies ranked around IDXX| Rank | Company | Market cap | Growth | Overall |
|---|---|---|---|---|
| 1 | 56.7B USD | 96 | 79 | |
| 2 | 40.2B USD | 92 | 73 | |
| 3 | 4.61T JPY (≈$31.3B) | 89 | 76 | |
| 4 | 43.30T KRW (≈$31.2B) | 86 | 68 | |
| 4 | 56.0B USD | 86 | 39 | |
| 21 | 8.24T JPY (≈$56.0B) | 63 | 75 | |
| 22 | 5.26T JPY (≈$35.8B) |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score